Word

C.

Status

Pending

Status Code

731

Status Date

Tuesday, March 12, 2024

Serial Number

97298868

Mark Type

3000

Filing Date

Monday, March 7, 2022

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

Cytokinetics, Incorporated - Owner At Publication

Classifications

5 human pharmaceuticals for the treatment of cardiovascular diseases, pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness, infectious diseases,neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin

42 research in the field of cellular assay screening and pharmaceutical discovery and development

The mark consists of stylized "C" with a circle between the opening.
Color is not claimed as a feature of the mark.

Trademark Events

Mar 13, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 12, 2024

Sou Extension 2 Granted

Mar 12, 2024

Sou Extension 2 Filed

Mar 12, 2024

Sou Teas Extension Received

Sep 9, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 7, 2023

Sou Extension 1 Granted

Sep 7, 2023

Sou Extension 1 Filed

Sep 7, 2023

Sou Teas Extension Received

Mar 21, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 19, 2022

Approved For Pub - Principal Register

Dec 17, 2022

Assigned To Examiner

Mar 12, 2022

Notice Of Design Search Code E-Mailed

Mar 11, 2022

New Application Office Supplied Data Entered

Mar 10, 2022

New Application Entered